June 19, 2018/by artemistheraArtemis Therapeutics Announces Two Recent Publications Highlighting Artemisone’s Activity Against Human Cytomegalovirus And Malaria
June 12, 2018/by artemistheraData Presented At The 31st International Conference For Antiviral Research Demonstrate Artemis Therapeutics’ Artemisone May Be An Effective Inhibitor Of Human CMV Replication
June 7, 2018/by artemistheraNew Data Demonstrate Artemis Therapeutics’ Artemisone May Be An Effective Inhibitor Of Human CMV Replication
April 16, 2018/by artemistheraArtemis Therapeutics Announces Additional Patent Issuance For Artemisone For The Treatment Of Viral Infections
November 28, 2017/by artemistheraArtemis Therapeutics Announces Issuance Of European Patent For Artemisone For The Treatment Of Viral Infections
November 6, 2017/by artemistheraArtemis Therapeutics Receives Orphan Drug Designation From U.S. Food And Drug Administration For Artemisone For The Treatment Of Malaria
